Bio Green Med Solution: ARKRAY's Innovative Glucose Monitoring System Enhances Long-Term Patient Care

Innovative Glucose Monitoring System Enhances Patient Care in Long-Term Facilities

In a significant development for the healthcare industry, ARKRAY USA, Inc. unveils the Assure® Titanium Blood Glucose Monitoring System (BGMS), specifically designed for post-acute and long-term care environments. The system is now available nationwide and has received FDA clearance, underpinned by clinical studies that validate its accuracy and reliability. The Assure® Titanium BGMS is tailored to meet the needs of skilled nursing facilities and endocrinology clinics, addressing the pressing demand for high-quality diabetes management solutions in these settings.

A standout feature of the Titanium BGMS is its innovative 24-hour quality control (QC) lockout, which necessitates daily QC testing. This critical functionality ensures that glucose readings are generated from verified devices, directly aligning with current clinical best practices. By effectively mitigating the risk of errors, this feature supports healthcare facilities in maintaining regulatory compliance, ultimately enhancing the quality of patient care. Toshio Serizawa, COO of ARKRAY USA, highlights that this new system signifies a substantial advancement in point-of-care glucose testing within long-term care, reinforcing ARKRAY’s commitment to providing tools that not only improve clinical accuracy but also facilitate adherence to industry regulations.

In addition to the technological advancements of the Titanium BGMS, ARKRAY USA offers comprehensive training and implementation services. These resources are designed to ensure that healthcare providers can seamlessly integrate the new system into their existing workflows, fostering a smooth transition and enhancing operational efficiency. With over 50 years of expertise and a presence in more than 80 countries, ARKRAY has established itself as a leader in diabetes management, particularly within professional healthcare markets in the United States.

The introduction of the Assure® Titanium BGMS marks a pivotal moment for ARKRAY USA as it continues to innovate within the clinical diagnostics landscape. The focus on enhancing patient care and regulatory compliance in long-term care environments underscores the company's dedication to improving healthcare outcomes for individuals living with diabetes. For healthcare providers interested in exploring this new technology, ARKRAY invites inquiries for demos and additional information through its website.